| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 03/23/2006 | WO2004110349A3 Sars t cell epitopes and methods for identifying same |
| 03/23/2006 | WO2004110340A3 Ctla-2 and uses thereof |
| 03/23/2006 | WO2004098502A3 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses. |
| 03/23/2006 | WO2004093786A3 Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith |
| 03/23/2006 | WO2004087057A3 Methods for inhibition of angiogenesis |
| 03/23/2006 | WO2004073659A3 HIV gp120 MIMOTOPE ANTIGEN |
| 03/23/2006 | WO2004064772A3 Methods and dosage forms with modified viscosity layers |
| 03/23/2006 | WO2003082202A3 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 03/23/2006 | US20060064163 Viscoelastic solution or gel formulation, and methods of treating a body site with the same |
| 03/23/2006 | US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 03/23/2006 | US20060063746 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 03/23/2006 | US20060063733 Methods of reducing an immune response |
| 03/23/2006 | US20060063731 In vivo inhibition of hepatitis B virus |
| 03/23/2006 | US20060063727 Tr4/tr2 response elements |
| 03/23/2006 | US20060063726 Crystallization in ethanol, propanol, or isopropanol solvent; acidification, evaporation; anticarcinogenic agents |
| 03/23/2006 | US20060063704 Somatostatin-dopamine chimeric analogs |
| 03/23/2006 | US20060063240 Introducing into the chromosome of the bacterium a set of in vitro constructed DNA fragments which contain regulatory elements for gene expression instead of the native elements of the regulatory region of the gene, and selecting the colonies with increased L-amino acid productivity |
| 03/23/2006 | US20060062860 Use of anemonin for treating aseptic inflammations |
| 03/23/2006 | US20060062800 Immunogens; envelope proteins; kits |
| 03/23/2006 | US20060062769 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 03/23/2006 | DE10037121B4 Verwendung einer konzentrierten und stabilisierten antipyretischen Zusammensetzung für den tiermedizinischen Gebrauch als Zusatz zu Tiernahrung Using a concentrated and stabilized antipyretic composition for veterinary use as an additive to animal feed |
| 03/23/2006 | CA2580717A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
| 03/22/2006 | EP1636385A2 Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |
| 03/22/2006 | EP1636359A2 Methods for treating pain |
| 03/22/2006 | EP1636236A1 Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 03/22/2006 | EP1636233A1 Cannabinoid receptor ligands and uses thereof |
| 03/22/2006 | EP1636231A2 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9- 4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same |
| 03/22/2006 | EP1636230A2 A1 adenosine receptor antagonists |
| 03/22/2006 | EP1636229A2 A1 adenosine receptor antogonists |
| 03/22/2006 | EP1636221A2 New azetidine compounds |
| 03/22/2006 | EP1636176A2 The polymorphic form a of 4- 6-acetyl-3- 3-(4-acetyl-3- hydroxy-2-propylphenylthio)propoxy -2-propylphenoxy butryric acid |
| 03/22/2006 | EP1636160A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 03/22/2006 | EP1635891A2 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition, insecticide use of lectin km+ to treat cicatrizations, use of lectin km+ to prepare immunomodulating medicament |
| 03/22/2006 | EP1635871A2 Methods and compositions for treating rheumatoid arthritis |
| 03/22/2006 | EP1635856A2 Saposin c-dops: a novel anti-tumor agent |
| 03/22/2006 | EP1635853A2 Topical composition for the treatment of skin disorders and methods of using the same |
| 03/22/2006 | EP1635841A2 Microbicidal, prophylactic and therapeutic effect of ctc-96 on papilloma viruses |
| 03/22/2006 | EP1635836A2 Prodrugs of heteroaryl compounds |
| 03/22/2006 | EP1635834A2 Novel compounds |
| 03/22/2006 | EP1635832A2 Combination therapy for the treatment of diabetes |
| 03/22/2006 | EP1635822A2 Methods and compositions for treating rheumatoid arthritis |
| 03/22/2006 | EP1635813A2 Combination therapy for the treatment of dyslipidemia |
| 03/22/2006 | EP1635812A2 Beta-lactamase inhibitors and methods of use thereof |
| 03/22/2006 | EP1635801A2 Methods for treating and preventing cardiac arrhythmia |
| 03/22/2006 | EP1635773A2 Combination therapy for the treatment of hypertension |
| 03/22/2006 | EP1635772A2 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 03/22/2006 | EP1635765A2 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 03/22/2006 | EP1635764A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
| 03/22/2006 | EP1635763A2 Method of treating neurodegenerative disease |
| 03/22/2006 | EP1635762A2 Low dose pharmaceutical powders for inhalation |
| 03/22/2006 | EP1635641A2 Mitotic kinesin inhibitors |
| 03/22/2006 | EP1313463B1 Fatty acid analogues for the treatment of cancer |
| 03/22/2006 | EP1212089B1 Synergistic combination of roflumilast and salmeterol |
| 03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/22/2006 | EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy |
| 03/22/2006 | CN1751236A Transgenic mice expressing human CD20 |
| 03/22/2006 | CN1751064A Hsp60 from arthrobacter |
| 03/22/2006 | CN1751031A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751030A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1750841A CLK-peptide and SLK-peptide |
| 03/22/2006 | CN1750830A Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention |
| 03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/22/2006 | CN1750759A Method of treating functional bowel disorders |
| 03/22/2006 | CN1750758A Compounds for the treatment of metabolic disorders |
| 03/22/2006 | CN1749252A Compounds useful to treat retroviral infections |
| 03/22/2006 | CN1246327C Novel 8A-and 9A-15-membered lactams |
| 03/22/2006 | CN1245988C Use of ATAZANAVIR in HIV therapy |
| 03/22/2006 | CN1245958C Controlled release hydroxy-ketone |
| 03/21/2006 | US7015477 Filtered backprojection algorithms for compton cameras in nuclear medicine |
| 03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
| 03/21/2006 | US7014867 Tablet comprising cetirizine and pseudoephedrine |
| 03/21/2006 | US7014842 Sunscreen composition |
| 03/21/2006 | CA2297292C Anhydrous compound for dyeing keratic fibres comprising the association of a water-soluble thickening polymer and of a nonionic amphiphilic polymer comprising at least one fatty chain |
| 03/16/2006 | WO2006004633A3 A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 03/16/2006 | WO2005055933A3 Treatment of psoriasis with rosiglitazone |
| 03/16/2006 | WO2005051310A3 Ctpss as modifiers of the pten pathway and methods of use |
| 03/16/2006 | WO2005046561A3 Multilayer dosage form comprising a matrix that influences release of a modulatory substance |
| 03/16/2006 | WO2005039486A3 Compounds and compositions as protein kinase inhibitors |
| 03/16/2006 | WO2005025506A3 Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation |
| 03/16/2006 | WO2005023187A3 Inhibitor of cardiac tachyarrhythmias |
| 03/16/2006 | WO2005016224A3 Novel therapeutic extracts and molecules for degenerative conditions |
| 03/16/2006 | WO2004056318A3 Method for treating amyloid disease |
| 03/16/2006 | WO2004019881A3 Hypocretin administration as a treatment for obesity |
| 03/16/2006 | US20060058388 Methods for treating ocular diseases via introxide and or polyhydroxy acid containing compounds |
| 03/16/2006 | US20060058381 Pharmaceutical formulation comprising (r)-bicalitamide |
| 03/16/2006 | US20060058327 Mitotic kinesin inhibitors |
| 03/16/2006 | US20060058217 Compositions and methods for treatment of ovarian cancer |
| 03/16/2006 | US20060057725 Therapeutic retroviral vectors for gene therapy |
| 03/16/2006 | US20060057644 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 03/16/2006 | US20060057210 for oral administration, reducing the range in daily dosages required to control pain in human patients; specified mean maximum plasma concentration |
| 03/16/2006 | US20060057072 Method for diagnosis and treatment of vascular disease |
| 03/16/2006 | US20060053652 Freeze-drying microscope stage apparatus and process of using the same |
| 03/16/2006 | DE10394212T5 Verfahren zur Herstellung einer antibakteriellen und antioxidierenden Fraktion aus Sanddornsamen (Hippophae rhamnoides L.) A process for the production of an antibacterial and antioxidant fraction from seeds of Seabuckthorn (Hippophae rhamnoides L.) |
| 03/15/2006 | EP1633858A2 Room temperature storage of organs |
| 03/15/2006 | EP1633785A2 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 03/15/2006 | EP1633772A2 Aav virions with decreased immunoreactivity and uses therefor |
| 03/15/2006 | EP1633740A2 Chemical compounds |
| 03/15/2006 | EP1633718A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-s |
| 03/15/2006 | EP1633695A2 Smooth muscle spasmolytic agents |
| 03/15/2006 | EP1633383A2 Use of erythropoietin in stroke recovery |